» Articles » PMID: 15297946

Treatment of Localized Esophageal Cancer

Overview
Journal Semin Oncol
Specialty Oncology
Date 2004 Aug 7
PMID 15297946
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The treatment of localized esophageal cancer (LEC) is controversial. The approaches that are used in daily practice include surgery or radiation alone, preoperative or postoperative radiation, preoperative or postoperative chemotherapy, and definitive or preoperative chemoradiation. The varied modalities used to treat LEC reflect both the lack of randomized trial data and the suboptimal results with current therapy. Nonetheless, the available data suggest that surgery and definitive concurrent chemoradiation represent two standard treatment options. The use of preoperative chemoradiation remains investigational, with phase III trials failing to demonstrate a consistent benefit for this option over chemoradiation or surgery alone. This review will examine the available data on the current treatment approaches in LEC.

Citing Articles

Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer.

Zlotnik O, Goshen-Lago T, Haddad R, Brenner B, Kundel Y, Ben-Aharon I Cancer Rep (Hoboken). 2021; 5(3):e1489.

PMID: 34350714 PMC: 8955071. DOI: 10.1002/cnr2.1489.


• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Kappel-Latif S, Zacherl J, Hejna M, Westerhoff M, Tamandl D, Ba-Ssalamah A Eur Surg. 2018; 50(4):160-166.

PMID: 30559831 PMC: 6290852. DOI: 10.1007/s10353-018-0527-z.


Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials.

Liu Y, Kou C, Su Y, Zhang Y, You Y, Zhang L Onco Targets Ther. 2017; 10:2971-2981.

PMID: 28652779 PMC: 5476713. DOI: 10.2147/OTT.S137474.


A randomized study to compare sequential chemoradiotherapy with concurrent chemoradiotherapy for unresectable locally advanced esophageal cancer.

Gupta A, Roy S, Majumdar A, Hazra A, Mallik C Indian J Med Paediatr Oncol. 2014; 35(1):54-9.

PMID: 25006285 PMC: 4080664. DOI: 10.4103/0971-5851.133722.


Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.

Wolf M, Zehentmayr F, Schmidt M, Holzel D, Belka C Radiat Oncol. 2012; 7:60.

PMID: 22501022 PMC: 3364842. DOI: 10.1186/1748-717X-7-60.